{"id":"corticosteroid-with-or-without-colchicine","safety":{"commonSideEffects":[{"rate":"10%","effect":"Nausea"},{"rate":"5%","effect":"Vomiting"},{"rate":"8%","effect":"Diarrhea"},{"rate":"12%","effect":"Abdominal pain"},{"rate":"15%","effect":"Headache"},{"rate":"20%","effect":"Fatigue"},{"rate":"18%","effect":"Insomnia"},{"rate":"12%","effect":"Dizziness"},{"rate":"10%","effect":"Muscle weakness"},{"rate":"25%","effect":"Weight gain"}]},"_chembl":{"chemblId":"CHEMBL107","moleculeType":"Small molecule","molecularWeight":"399.44"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Corticosteroids exert their effects by binding to the glucocorticoid receptor, which then translocates to the nucleus and regulates gene expression.","oneSentence":"Glucocorticoid receptor agonist","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T03:29:01.155Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Rheumatoid arthritis"},{"name":"Psoriatic arthritis"}]},"trialDetails":[{"nctId":"NCT04381936","phase":"PHASE3","title":"Randomised Evaluation of COVID-19 Therapy","status":"RECRUITING","sponsor":"University of Oxford","startDate":"2020-03-19","conditions":"Severe Acute Respiratory Syndrome","enrollment":70000},{"nctId":"NCT05805930","phase":"PHASE3","title":"Therapeutic Approach in Colchicine-resistant Recurrent pEricarditis in Children","status":"NOT_YET_RECRUITING","sponsor":"Istituto Giannina Gaslini","startDate":"2023-06-01","conditions":"Pericarditis","enrollment":48},{"nctId":"NCT04654416","phase":"","title":"Clinical Outcome of Patients With COVID-19 Pneumonia Treated With Corticosteroids and Colchicine","status":"COMPLETED","sponsor":"Clínica Medellín - Grupo Quirónsalud","startDate":"2020-03-20","conditions":"Covid-19","enrollment":301}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":408676,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"Corticosteroid with or without colchicine","genericName":"Corticosteroid with or without colchicine","companyName":"Clínica Medellín - Grupo Quirónsalud","companyId":"cl-nica-medell-n-grupo-quir-nsalud","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Glucocorticoid receptor agonist Used for Rheumatoid arthritis, Psoriatic arthritis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}